Serge Lapointe has extensive experience in patent protection in the life sciences sector in Canada, the United States and abroad. Serge combines his vast knowledge and his experience when drafting patent applications and preparing opinions on the validity and infringement of biotechnology, pharmaceutical and chemical patents. He gets often involved into intellectual property due diligence investigations.
Serge has more than 20 years of experience working in firms and in industry, and he has acquired in-depth knowledge of the scientific and regulatory aspects of drug development. His ability to examine technology from a pragmatic business perspective is an added value for clients.
Serge responds effectively to the legal and commercial needs of a varied clientele from the genomics, proteomics, pharmaceutical products and chemical industries.
He has considerable experience in assisted reproductive technologies, diseases of the central nervous system, obesity, diabetes, virology, microbiology, genetic markers, blood and nephrological disorders, stem cells, nutraceuticals, and green technologies.
